FrancophonIA/ELRC3.0 huggingface dataset:
English: On 11 August 2005, Sanofi Pasteur MSD on behalf of all the Marketing Authorisation Holders (see Annex I) presented to the EMEA a referral under Article 30 of Directive 2001/83/EC, as amended, in order to harmonise the national SPCs of the medicinal product STAMARIL and associated names.
Lithuanian: I priedą) kreipimąsi pagal pataisytą Direktyvos 2001/83/EB 30 straipsnį, siekdama suderinti nacionalines STAMARIL ir kitų susijusių pavadinimų preparatų charakteristikų santraukas (SPC).
English: Ref. EMEA/610140/2008
Lithuanian: EMEA/610140/2008
English: In both cases, all medicines were to be started at the same time.
Lithuanian: Abiem atvejais visi preparatai turėjo būti pradėti vartoti tuo pačiu metu.
English: The company had initiated an appeal process, but this had not yet finished when the company withdrew.
Lithuanian: Bendrovė pradėjo apeliacijos procedūrą, kuri dar nebuvo pasibaigusi, kai bendrovė paraišką atsiėmė.
English: International non-proprietary name (INN): docetaxel
Lithuanian: Tarptautinis nepatentinis pavadinimas (INN): docetakselis
English: London, 20 November 2008 Doc.
Lithuanian: Londonas, 2008 m.
English: In both groups, trastuzumab treatment was continued for a year.
Lithuanian: Abiejų grupių pacientai trastuzumabu buvo gydomi vienus metus.
English: The letters from the company notifying the EMEA of the withdrawal of the application are available here and here.
Lithuanian: Kokias paraiškos atsiėmimo priežastis nurodė bendrovė? Bendrovės laišką, informuojantį EMEA dėl paraiškos atsiėmimo, galima rasti čia ir čia.
English: With the skeleton still in place, the cells cannot divide and they eventually die.
Lithuanian: Sustabdžius branduolio skilimą, ląstelės negali dalytis ir galų gale žūsta.
English: Docetaxel affects not only cancer cells, but also non-cancer cells such as blood cells, which can cause side effects.
Lithuanian: Docetakselis veikia ne tik vėžines, bet ir nevėžines ląsteles, pavyzdžiui, kraujo ląsteles, o tai gali sukelti šalutinių reiškinių.
English: The main measure of effectiveness was how long the patients survived until their cancer came back.
Lithuanian: Pagrindinis veiksmingumo rodiklis buvo laikas, kurį vėžys neatsinaujino.
English: What is Taxotere/Docetaxel Winthrop?
Lithuanian: Kas yra Taxotere/Docetaxel Winthrop?
English: The study compared the effectiveness of the following treatment combinations, which were used in addition to surgery:
Lithuanian: Šiame tyrime buvo lyginamas šių vaistų derinių, skirtų kartu su chirurginiu gydymu, veiksmingumas:
English: • together with trastuzumab (another anticancer medicine), following treatment with doxorubicin and cyclophosphamide;
Lithuanian: • trastuzumabu (kitu vaistu nuo vėžio), po gydymo doksorubicinu ir ciklofosfamidu;
English: • together with trastuzumab and carboplatin (another anticancer medicine).
Lithuanian: • trastuzumabu ir karboplatina (kitais vaistais nuo vėžio).
English: The evaluation had finished and the CHMP had given a negative opinion.
Lithuanian: Kuriuo paraiškos nagrinėjimo etapu paraiška atsiimta? Baigęs preparato vertinimą, CHMP pateikė neigiamą nuomonę.
English: The CHMP was also concerned that the company did not provide sufficient clinical evidence to justify the use of the combination of Taxotere/Docetaxel Winthrop, carboplatin and trastuzumab.
Lithuanian: Be to, CHMP nerimą kėlė tai, kad bendrovė nepateikė pakankamai klinikinių įrodymų Taxotere/Docetaxel Winthrop, karboplatinos ir trastuzumabo derinio naudojimui pagrįsti.
English: Therefore, at the time of the withdrawal, the CHMP's view was that a benefit of Taxotere/Docetaxel Winthrop had not been sufficiently demonstrated and any benefits did not outweigh the identified risks.
Lithuanian: Taigi paraiškos atsiėmimo metu CHMP laikėsi nuomonės, kad preparato Taxotere/Docetaxel Winthrop teikiama nauda nebuvo pakankamai įrodyta ir preparato teikiama nauda nėra didesnė už nustatytą jo keliamą riziką.
English: What were the main concerns of the CHMP?
Lithuanian: Kas CHMP tuo metu kėlė didžiausią susirūpinimą?
English: Based on the review of the data and the company's response to the CHMP list of questions, at the time of the withdrawal, the CHMP had given a negative opinion and did not recommend a marketing authorisation for Taxotere/Docetaxel Winthrop in the treatment of patients with operable breast cancer whose tumours overexpress HER2 in combination with trastuzumab, with or without carboplatin.
Lithuanian: Remdamasis peržiūrėtais duomenimis ir atsakymais, kuriuos bendrovė pateikė į CHMP sudaryto sąrašo klausimus paraiškos atsiėmimo metu, CHMP priėmė neigiamą nuomonę ir rekomendavo nesuteikti preparato Taxotere/Docetaxel Winthrop rinkodaros teisės pacientams, sergantiems galimu operuoti krūties vėžiu, gaminančiu didelį kiekį HER2, kartu vartojantiems trastuzumabo su karboplatina ar be jos.
English: Questions and answers on the withdrawal of the application for a change to the marketing authorisation for Taxotere/Docetaxel Winthrop
Lithuanian: Klausimai ir atsakymai dėl paraiškos iš dalies pakeisti vaistinio preparato Taxotere/Docetaxel Winthrop rinkodaros teisę atsiėmimo
English: There are no consequences on the use of Taxotere/Docetaxel Winthrop in its authorised indications, for which the balance of benefits and risks remains unchanged.
Lithuanian: Taxotere/Docetaxel Winthrop naudojimas pagal patvirtintą indikaciją, pagal kurią vartojamo vaisto naudos ir rizikos santykis nesikeičia, išlieka toks pat.
English: What are the consequences of the withdrawal for patients undergoing clinical trials with Taxotere/Docetaxel Winthrop?
Lithuanian: Kokios atsiėmimo pasekmės pacientams, dalyvaujantiems Taxotere/Docetaxel Winthrop klinikiniuose tyrimuose?
English: • the combination of Taxotere/Docetaxel Winthrop, trastuzumab and carboplatin for 18 weeks.
Lithuanian: • 18 savaičių trukusio gydymo Taxotere/Docetaxel Withrop, trastuzumabo ir karboplatinos deriniu.
English: What is happening for Taxotere/Docetaxel Winthrop for the treatment of other types of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma and head and neck cancer?
Lithuanian: Kaip keičiasi Taxotere/Docetaxel Winthrop naudojimas kitų tipų krūties vėžiui, nesmulkialąsteliniam plaučių vėžiui, prostatos vėžiui, skrandžio adenokarcinomai ir galvos bei kaklo vėžiui gydyti?
English: On 14 November 2008, Sanofi-Aventis Pharma S.A. officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a new indication for Taxotere/Docetaxel Winthrop, to add the treatment of patients with operable breast cancer whose tumours overexpress HER2 in combination with trastuzumab, with or without carboplatin.
Lithuanian: A.“ oficialiai pranešė Žmonėms skirtų vaistinių preparatų komitetui (CHMP) apie savo pageidavimą atsiimti naujos Taxotere/Docetaxel Winthrop indikacijos paraišką, kuria buvo prašoma įtraukti galimu operuoti HER2 teigiamu krūties vėžiu sergančių pacienčių gydymą trastuzumabo deriniu su karboplatina ar be jos.
English: In these patients, Taxotere/Docetaxel Winthrop is used in addition to surgery to remove the tumour, together with doxorubicin and cyclophosphamide (other anticancer medicines).
Lithuanian: Pastaruoju vėžiu sergantiems pacientams Taxotere/Docetaxel Winthrop naudojamas kaip priemonė, papildanti tumoro šalinimo operaciją, kartu skiriant doksorubicino ir ciklofosfamido (kitų vaistų nuo vėžio).
English: Taxotere/Docetaxel Winthrop is also used in advanced or metastatic non-small cell lung cancer, in prostate cancer, in metastatic gastric adenocarcinoma (a type of stomach cancer) and in advanced head and neck cancer.
Lithuanian: Taxotere/Docetaxel Winthrop taip pat gydomas pažengęs ar metastazinis nesmulkialąstelinis plaučių vėžys, prostatos vėžys, metastazinės skrandžio adenokarcinomos (skrandžio vėžio tipas) ir pažengęs galvos ir kaklo vėžys.
English: Taxotere/Docetaxel Winthrop has been studied in one main study involving over 3,000 women with HER2-expressing breast cancer that could be treated with surgery.
Lithuanian: Kokius dokumentus bendrovė pateikė CHMP kartu su paraiška? Taxotere/Docetaxel Winthrop buvo tiriamas viename pagrindiniame tyrime su 3 000 moterų, sergančių HER2 gaminančiu krūties vėžiu, kurį buvo galima gydyti chirurginiu būdu.
English: Taxotere/Docetaxel Winthrop is a concentrate and solvent, which are made up into a solution for infusion (drip into a vein).
Lithuanian: Taxotere/Docetaxel Winthrop yra koncentratas ir tirpiklis, iš kurių gaminamas infuzinis (į veną lašinamas) tirpalas. Jame yra veikliosios medžiagos docetakselio.
English: The CHMP was concerned that it was not possible to establish the benefits of the treatment combinations including Taxotere/Docetaxel Winthrop when used in addition to surgery, because of the way the single main study was designed.
Lithuanian: CHMP susirūpinimą kėlė tai, kad atsižvelgiant į tai, kaip vienintelis atliktas tyrimas buvo atliktas, nebuvo įmanoma įvertinti Taxotere/Docetaxel Winthrop ir kitų vaistų derinių, skiriamų kartu su chirurginiu gydymu, naudos.
English: Taxotere/Docetaxel Winthrop was expected to be used in addition to surgery to remove the tumour in the following treatment combinations:
Lithuanian: Taxotere/Docetaxel Winthrop buvo numatyta skirti kaip tumoro šalinimo operaciją papildančią priemonę kartu su šiais preparatais:
English: • the combination of doxorubicin and cyclophosphamide for 12 weeks, followed by
Lithuanian: • 12 mėnesių trukusio gydymo doksorubicino ir ciklofosfamido deriniu, po kurio buvo taikomas 12 savaičių gydymas Taxotere/Docetaxel Winthrop, skiriamo kartu trastuzumabu ar be jo;
English: The active substance in Taxotere/Docetaxel Winthrop, docetaxel, belongs to the group of anticancer medicines known as the ‘taxanes'.
Lithuanian: Kaip tikimasi veiks Taxotere/Docetaxel Winthrop? Veiklioji Taxotere/Docetaxel Winthrop medžiaga docetakselis priklauso taksanų, vaistų nuo vėžio, grupei.
English: Docetaxel blocks the ability of cells to destroy the internal ‘skeleton' that allows them to divide and multiply.
Lithuanian: Docetakselis sustabdo ląstelių branduolio skilimą, t. y.
English: Taxotere/Docetaxel Winthrop was also expected to be used to treat breast cancer that can be treated with surgery when the cancer has been shown to be ‘expressing' large amounts of HER2: this is a type of cancer that produces (expresses) a specific protein called HER2 in large quantities on the surface of the tumour cells.
Lithuanian: tokio tipo vėžį, kuris tumoro ląstelių paviršiuje gamina (ekspresuoja) didelį kiekį specifinio baltymo, vadinamojo HER2.
English: It is used in breast cancer that is advanced or ‘metastatic' (has spread to other parts of the body), and in breast cancer that can be treated with surgery.
Lithuanian: Taxotere/Docetaxel Winthrop - vaistas nuo vėžio. Juo gydomas pažengęs ar metastazinis (iš pradinio židinio į kitas kūno dalis išplitæs) krūties vėžys ir toks krūties vėžys, kurį galima gydyti chirurginiu būdu.
English: The company informed the CHMP that there are no consequences for patients currently included in clinical trials with Taxotere/Docetaxel Winthrop.
Lithuanian: Bendrovė pranešė CHMP, kad pacientams, šiuo metu dalyvaujantiems preparato Taxotere/Docetaxel Winthrop klinikiniuose tyrimuose, paraiškos atsiėmimas neturės jokių padarinių. Jei dalyvaujate klinikiniuose tyrimuose ir pageidaujate gauti išsamesnės informacijos apie gydymą, kreipkitės į Jus gydantį gydytoją.
English: 183 11 Täby Sweden
Lithuanian: 183 11 Täby Švedija
English: Gentsesteenweg 615 1080 Brussels Belgium
Lithuanian: Gentsesteenweg 615 1080 Brussels Belgija
English: 75014 Paris - France
Lithuanian: 75014 Paris - Prancūzija
English: 1800 Vilvoorde Belgium
Lithuanian: 1800 Vilvoorde Belgija
English: 2710-444 Sintra Portugal
Lithuanian: 2710-444 Sintra Portugalija
English: G. LYRA 25, KIFISSIA
Lithuanian: LYRA 25, KIFISSIA
English: 140 00 Czech Republic
Lithuanian: 140 00 Čekijos Respublika
English: 1998-025 Lisboa Portugal
Lithuanian: 1998-025 Lisboa Portugalija
English: 635 00 Brno Czech republic
Lithuanian: 635 00 Brno Čekijos Respublika
English: 2794-093 Carnaxide Portugal
Lithuanian: 2794-093 Carnaxide Portugalija
English: 41 Chalton street, London, NW1 1JD, United Kingdom
Lithuanian: 41 Chalton street, London, NW1 1JD, Jungtinė Karalystė
English: Parque Empresarial San Fernando San Fernando de Henares Madrid 28830 spain
Lithuanian: Parque Empresarial San Fernando San Fernando de Henares Madrid 28830 Ispanija
English: Edifício 7 - 3º Piso 2740-244 Porto Salvo Portugal
Lithuanian: Edifício 7 - 3º Piso 2740-244 Porto Salvo Portugalija
English: 18th km Athens-Lamia National Road 146 71 Nea Erythrea Greece
Lithuanian: 18th km Athens-Lamia National Road 146 71 Nea Erythrea Graikija
English: Novartis Finland Oy Metsänneidonkuja 10 02130 Espoo Finland
Lithuanian: Novartis Finland Oy Metsänneidonkuja 10 02130 Espoo Suomija
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states
Lithuanian: I priedas Vaistų pavadinimų, vaistų formų, stiprumų, vartojimo būdų, rinkodaros teisės turėtojų valstybėse narėse sąrašas
English: 2740-271 Porto Salvo Portugal
Lithuanian: 2740-271 Porto Salvo Portugalija
English: 92300 Levallois-PerretFrance
Lithuanian: 92300 Levallois-PerretPrancūzija
English: Brno Czech Republic
Lithuanian: Brno Čekijos Respublika
English: Rua João de Deus, 19Venda Nova 2700-487 Amadora Portugal
Lithuanian: Rua João de Deus, 19Venda Nova 2700-487 Amadora Portugalija
English: Wincentego st. Pola 21 58-500, Jelenia Góra, Poland
Lithuanian: Pola 21 58-500, Jelenia Góra, Lenkija
English: D-06796 Brehna Germany
Lithuanian: D-06796 Brehna Vokietija
English: IAMATICA MON. LTD CHALANDRIOU 6A AGIA PARASKEVI
Lithuanian: LTD CHALANDRIOU 6A AGIA PARASKEVI
English: Cediat Mediffusion 11 bis rue du Colisée 75008 Paris - France
Lithuanian: Cediat Mediffusion 11 bis rue du Colisée 75008 Paris - Prancūzija
English: Rua Alfredo da Silva, 16 2610-016 Amadora Portugal
Lithuanian: Rua Alfredo da Silva, 16 2610-016 Amadora Portugalija
English: Av. José MalhoaEdifício Malhoa Plaza nº piso-escritório 2.2 1070-325 Lisboa Portugal
Lithuanian: José MalhoaEdifício Malhoa Plaza nº piso-escritório 2.2 1070-325 Lisboa Portugalija
English: Laboratoire Pharmy II Strategy center 26 rue des Gaudines 78100 Saint Germain en Laye - France
Lithuanian: Laboratoire Pharmy II Strategy center 26 rue des Gaudines 78100 Saint Germain en Laye - Prancūzija
English: Zambon France 13 rue René Jacques 92138 Issy les Moulineaux CedexFrance
Lithuanian: Zambon France 13 rue René Jacques 92138 Issy les Moulineaux CedexPrancūzija
English: A. HATZIANTONOGLOUVELTIPHARM LTD DELIGIORGI 55-57
Lithuanian: HATZIANTONOGLOUVELTIPHARM LTD DELIGIORGI 55-57
English: Labesfal - Laboratórios Almiro, S.A.
Lithuanian: Labesfal - Laboratórios Almiro, S.
English: Novartis Hungária Kft. Bartók Béla út 43-47.
Lithuanian: Bartók Béla út 43-47.
English: 61118 Bad Vilbel, Germany
Lithuanian: 61118 Bad Vilbel, Vokietija
English: D-61118 Bad Vilbel Germany
Lithuanian: D-61118 Bad Vilbel Vokietija
English: S.J.A.
Lithuanian: J.A.
English: UCB Pharma GmbH Geiselbergstraße 1719/2, 5.Stock 1110 Wien, Austria
Lithuanian: UCB Pharma GmbH Geiselbergstraße 1719/2, 5.Stock 1110 Wien, Austrija
English: Novartis Pharma GmbH Stella-Klein-Löw-Weg 17 A-1020 Wien, Austria
Lithuanian: Novartis Pharma GmbH Stella-Klein-Löw-Weg 17 A-1020 Wien, Austrija
English: Novartis Pharma SAS 2-4 rue Lionel Terray 92500 Rueil-MalmaisonFrance
Lithuanian: Novartis Pharma SAS 2-4 rue Lionel Terray 92500 Rueil-MalmaisonPrancūzija
English: ToLife - Produtos Farmacêuticos, S.A. Avenida do Forte, 3Edificio Suécia III, Piso 1
Lithuanian: Avenida do Forte, 3Edificio Suécia III, Piso 1
English: ALFA WASSERMANN, S.P.A.Via Enrico Fermi, 1 Alanno Scalo (Pescaro) 65020 ITALIA
Lithuanian: ALFA WASSERMANN, S.P.A.Via Enrico Fermi, 1 Alanno Scalo (Pescaro) 65020 ITALIJA
English: D-83607 Holzkirchen Germany
Lithuanian: D-83607 Holzkirchen Vokietija
English: LEOVAN M. LEON AND CO
Lithuanian: LEON AND CO
English: PHARMACEUTICALS LTD. 425 Irakliou Avenue, 14122 Atena, Grecia
Lithuanian: 425 Irakliou Avenue, 14122 Atena, Graikija
English: Ostostabil 50 I.E.
Lithuanian: Ostostabil 50 I.
English: 200 IU / metered dose
Lithuanian: 200 NE/ metered dose
English: Czech Republic
Lithuanian: Čekijos Respublika
English: Zona Industrial do Lagedo 3465-157 Santiago de Besteiros Portugal
Lithuanian: Zona Industrial do Lagedo 3465-157
English: Novartis Healthcare A/S, Lyngbyvej 172, DK2100, København Ø, Denmark
Lithuanian: Novartis Healthcare A/S, Lyngbyvej 172, DK2100, København Ø, Danija
English: LABORATORIO PADRO, S.A.Gran Via de les Corts Catalanes, 764 barcelona 08013 Spain
Lithuanian: LABORATORIO PADRO, S.A.Gran Via de les Corts Catalanes, 764 barcelona 08013
English: Germany mibe GmbH Arzneimittel Münchener Str. 15
Lithuanian: Vokietija mibe GmbH Arzneimittel Münchener Str.
English: Laboratório NormalProdutos Farmacêuticos, S.A.
Lithuanian: Laboratório NormalProdutos Farmacêuticos, S.
English: LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA Via Licinio, 11
Lithuanian: LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA Via Licinio, 11 22036 Erba - COMO
English: Osteodon 200 IU.
Lithuanian: Osteodon 200 I.U.
English: D-22946 Trittau Germany
Lithuanian: D-22946 Trittau Vokietija
English: Novartis Healthcare A/S, Lyngbyvej 172, DK-2100 Østerbro, Denmark
Lithuanian: Novartis Healthcare A/S, Lyngbyvej 172, DK-2100 Østerbro, Danija
English: 2200 i.e./ml
Lithuanian: 2200 UI / ml
English: Arrowblue Produtos Farmacêuticos S.A. Av. D. João II, Torre Fernão de Magalhães10 Esqº
Lithuanian: João II, Torre Fernão de Magalhães10 Esqº
English: FARMACEUTICA, S.A.Gran Via de les Corts Catalanes, 764 Barcelona 08013 Spain
Lithuanian: NOVARTIS FARMACEUTICA, S.A.Gran Via de les Corts Catalanes, 764 Barcelona 08013 Ispanija
English: Novartis Norge AS, Postboks 4284 Nydalen
Lithuanian: Novartis Norge AS, Postboks 4284 Nydalen 0401 Oslo, Norvegija
English: D-90429 Nürnberg, Germany
Lithuanian: D-90429 Nürnberg, Vokietija
English: Calcitonin 'Novartis' 200 I.E. - Nasalspray
Lithuanian: Calcitonin 'Novartis' 200 I.E.
English: Miacalcic 200 i.e./odmerek pršilo za nos, raztopina
Lithuanian: /odmerek pršilo za nos, raztopina
English: Calcitonin 'Novartis' 100 I.E. - Nasalspray
Lithuanian: Calcitonin 'Novartis' 100 I.E.
English: D-89079 Ulm Germany
Lithuanian: D-89079 Ulm Vokietija
English: SANOFI AVENTIS, S.A.Josep Plá, 2
Lithuanian: SANOFI AVENTIS, S.A.Josep Plá, 2 Barcelona 08019 ISPANIJA
English: D-90429 Nürnberg Germany
Lithuanian: D-90429 Nürnberg Vokietija
English: Farmoz - Sociedade Técnico Medicinal, S.A. Rua da Tapada Grande, 2, Abrunheira 2710-089 Sintra Portugal
Lithuanian: Rua da Tapada Grande, 2, Abrunheira 2710-089 Sintra Portugalija
English: Miacalcic 100 i.e./ml raztopina za injiciranje ali infundiranje
Lithuanian: /ml raztopina za injiciranje ali infundiranje
English: NYCOMED HELLAS S.A. KIFISSIAS AVENUE 196, HALANDRI 15232
Lithuanian: KIFISSIAS AVENUE 196, HALANDRI 15232
English: NYCOMED HELLAS S.A. KIFISSIAS AVENUE 196, HALANDRI 15231
Lithuanian: KIFISSIAS AVENUE 196, HALANDRI 15231
English: Novartis Pharma GmbH, Roonstrasse 25, Nurnberg 90429, Germany
Lithuanian: Novartis Pharma GmbH, Roonstrasse 25, Nurnberg 90429, Vokietija
English: Pharmaceuticals Uk Ltd, Frimley Business Park, Frimley, Camberley, Surrey, UK
Lithuanian: Pharmaceuticals UK Ltd, Frimley Business Park, Frimley, Camberley, Surrey, JK
English: 30TH KM ATHENSLAVRION AVENUE MARKOPOULO 19003
Lithuanian: MEDHEL HELLAS PHARMACEUTICAL INDUSTRY 30TH KM ATHENSLAVRION AVENUE MARKOPOULO 19003
English: Ratiopharm GmbH Graf-Arco-Str. 3., Ulm
Lithuanian: Ratiopharm GmbH Graf-Arco-Str.
English: Pharmaceuticals UK Ltd, Frimley, Camberley, Surrey GU16 7SR, UK
Lithuanian: Pharmaceuticals UK Ltd, Frimley, Camberley, Surrey GU16 7SR, JK
English: NOVARTIS PHARMA GmbH,Roonstrasse 25D90429 Nürnberg, Germania
Lithuanian: NOVARTIS PHARMA GmbH,Roonstrasse 25D90429 Nürnberg, Vokietija
English: Novartis Pharma GmbH, Roonstrasse 25, D90429 Nuernberg, Germany
Lithuanian: Novartis Pharma GmbH, Roonstrasse 25, D90429 Nuernberg, Vokietija
English: Slovak Republic ratiopharm International GmbH
Lithuanian: Slovakija ratiopharm International GmbH Graf-Arco-Strasse
English: Calcitonine-Sandoz 100 IE/ml, oplossing voor injectie en infusie solution for injection/infusion subcutaneous use, intramuscular use, intravenous use
Lithuanian: Calcitonine-Sandoz 100 IE/ml, oplossing voor injectie en infusie
English: Miacalcic solution for injection/infusion
Lithuanian: Miacalcic Solution for Injection 100IU/ml
English: Karil 200 I.E. Nasenspray
Lithuanian: Karil 200 I.E.
English: Calcitonin Sandoz 100 I.E. / Sprühstoß Nasenspray
Lithuanian: Calcitonin Sandoz 100 I.E.
English: 200 IU/dose, 2000 IU/ML
Lithuanian: 200 IU/ml
English: 0,25 mg powder and solvent for solution for injection intramuscular use, intravenous use, subcutaneous use
Lithuanian: 0,25 mg milteliai ir tirpiklis injekciniam tirpalui leisti į raumenis, leisti į veną,
English: TAD Pharma GmbH Heinz-Lohmann-Str. 5 D-27472 Cuxhaven Germany
Lithuanian: 5 D-27472 Cuxhaven Vokietija
English: MIACALCIC 100 NE/ml oldatos injekció és infúzió solution for injection/infusion subcutaneous use, intramuscular use, intravenous use
Lithuanian: MIACALCIC 100 NE/ml oldatos injekció és infúzió
English: 0,50 mg powder and solvent for solution for injection intramuscular use, intravenous use, subcutaneous use
Lithuanian: 0,50 mg milteliai ir tirpiklis injekciniam tirpalui leisti į raumenis, leisti į veną,
English: OSPOR 200 UI solución para pulverización nasal 200 IU
Lithuanian: OSPOR 200 UI solución para pulverización nasal
English: 200 IU/dose nasal spray, liquid nasal use
Lithuanian: 200 IU/dose nosies purškalas, skystis
English: MIACALCIC 50 NE/ml oldatos injekció és infúzió solution for injection/infusion subcutaneous use, intramuscular use, intravenous use
Lithuanian: MIACALCIC 50 NE/ml oldatos injekció és infúzió
English: TONOCALCIN 200 IU nosová aerodisperzia 200 IU/0,1 ml
Lithuanian: TONOCALCIN 200 IU nosová aerodisperzia
English: Calcitonine Pharmy II 50 IU/ml solution for injection intramuscular use, intravenous use, subcutaneous use
Lithuanian: Calcitonine Pharmy II 50 IU/ml leisti į raumenis, leisti į veną,
English: solution for injection/infusion intravenous use, intramuscular use, subcutaneous use
Lithuanian: injekcinis / infuzinis tirpalas leisti į veną, leisti į raumenis, leisti po oda
English: CALCITONINA SANDOZ 50 UI/ml solution for injection and infusion intravenous use, intramuscular use, subcutaneous use
Lithuanian: CALCITONINA SANDOZ 50 UI/ml injekcinis ir infuzinis tirpalas leisti į veną, leisti į raumenis, leisti po oda
English: Pharmaceuticals UK Ltd. Frimley Business Park, Frimley Camberley, Surrey GU16 7SR, United Kingdom
Lithuanian: Frimley Business Park, Frimley Camberley, Surrey GU16 7SR, Jungtinė Karalystė
English: Miacalcic Nasal 200 200 IU/dose nasal spray nasal use
Lithuanian: Miacalcic Nasal 200 200 IU/dose nosies purškalas
English: Calcitonine Pharmy II 100 IU/ml solution for injection intramuscular use, intravenous use, subcutaneous use
Lithuanian: Calcitonine Pharmy II 100 IU/ml leisti į raumenis, leisti į veną,
English: 50 IU/1ML AMP solution for injection intravenous use, intramuscular use, subcutaneous use
Lithuanian: 50 IU/1ML AMP injekcinis tirpalas leisti į veną, leisti į raumenis, leisti po oda
English: pre-filled syringe subcutaneous use, intramuscular use, intravenous use
Lithuanian: /ml injekcinis / infuzinis tirpalas leisti po oda, leisti į raumenis, leisti į veną
English: 100 IU/1ML AMP solution for injection intravenous use, intramuscular use, subcutaneous use
Lithuanian: 100 IU/1ML AMP injekcinis tirpalas leisti į veną, leisti į raumenis, leisti po oda
English: CALCO 50 NE/ml injekció solution for injection subcutaneous use, intramuscular use, intravenous use
Lithuanian: 50 NE/ml injekcinis / infuzinis tirpalas leisti po oda, leisti į raumenis, leisti į veną
English: powder and solvent for solution for injection intramuscular use, subcutaneous use
Lithuanian: milteliai ir tirpiklis injekciniam tirpalui leisti į raumenis, leisti po oda
English: (Invented) name
Lithuanian: (Sugalvotas) pavadinimas